Bravos Afterloader System
Payments companies reported to CMS as associated with Bravos Afterloader System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bravos Afterloader System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bravos Afterloader System
These are the largest totals companies reported as associated with Bravos Afterloader System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Andrew Farach | Houston, TX | Radiation Oncology | $23,328.11 |
| Jyoti Mayadev | San Diego, CA | Radiation Oncology | $13,417.33 |
| Yasmin Hasan | Chicago, IL | Radiation Oncology | $12,034.09 |
| Neil Taunk | Philadelphia, PA | Radiation Oncology | $10,486.04 |
| Timothy Showalter | Charlottesville, VA | Radiation Oncology | $6,362.86 |
| Phillip Pifer | Pittsburgh, PA | Radiation Oncology | $3,783.70 |
| Stella Lymberis | New York, NY | Radiation Oncology | $2,981.13 |
| John David | Tampa, FL | Radiation Oncology | $2,873.73 |
| Drew Moghanaki | Los Angeles, CA | Radiation Oncology | $2,500.00 |
| Marisa Kollmeier | New York, NY | Radiation Oncology | $1,877.05 |
Prescribed Bravos Afterloader System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.